A growing legal challenge against Johnson & Johnson is unfolding in the United Kingdom, with thousands alleging the company knowingly sold baby powder contaminated with asbestos, a known carcinogen. The claims, mirroring extensive litigation already underway in the United States, center on accusations that Johnson & Johnson was aware of the presence of harmful minerals in its talc-based products for decades but failed to warn consumers or take adequate action.
The latest development involves a group of Scottish women who have initiated legal proceedings, adding to the already substantial number of claimants. This legal action builds on a larger case filed in October 2025, encompassing approximately 3,000 people across the UK, all seeking damages for cancers allegedly linked to the use of Johnson & Johnson’s baby powder. The core of the lawsuit revolves around internal documents and scientific reports that, according to the claimants’ lawyers, demonstrate the company’s knowledge of asbestos contamination as early as the 1960s.
KP Law is representing the claimants, alleging that Johnson & Johnson and its subsidiary, Kenvue Ltd, were aware that their mineral-based talcum powder contained fibrous forms of talc, as well as tremolite and actinolite – minerals classified as asbestos when in fibrous form. These minerals are linked to potentially deadly cancers, including mesothelioma and ovarian cancer. The lawsuit further alleges that, despite this knowledge, Johnson & Johnson did not issue warnings on product packaging and instead engaged in marketing campaigns portraying the powder as safe and pure.
Talcum Powder and Cancer: A History of Litigation
Johnson & Johnson denies the allegations, maintaining that its baby powder “was compliant with any required regulatory standards, did not contain asbestos, and does not cause cancer.” However, the company has faced significant legal challenges in the US, where numerous lawsuits have resulted in billions of dollars in damages awarded to claimants. Although Johnson & Johnson has successfully appealed some of these rulings, the financial and reputational impact has been substantial.
The sale of baby powder containing talc was discontinued in the UK in 2023, a move that came amid increasing scrutiny and legal pressure. This decision followed similar actions taken by the company in North America, where it ceased production and sales of talc-based baby powder in 2020, citing declining demand and ongoing litigation. The shift to cornstarch-based baby powder was presented as a proactive measure to address consumer concerns, though the company continues to defend the safety of its previous talc-based products.
The Scale of the UK Claim
Lawyers representing the claimants estimate that the total damages sought in the UK could reach hundreds of millions of pounds, potentially making this the largest product liability case in British history. The claims center on the alleged failure to warn consumers about the potential risks associated with asbestos contamination. The lawsuit alleges that Johnson & Johnson prioritized profits over consumer safety, continuing to market and sell a product they knew, or should have known, posed a health hazard.
The legal arguments hinge on establishing a direct link between the asbestos-contaminated talcum powder and the development of cancer in the claimants. This involves presenting scientific evidence, internal company documents, and expert testimony to demonstrate that the exposure to asbestos through the use of Johnson & Johnson’s baby powder significantly increased the risk of developing mesothelioma and ovarian cancer.
What the Documents Reveal
The court papers filed in the UK case reportedly include internal memos and scientific reports from Johnson & Johnson dating back to the 1960s. These documents, according to the claimants’ lawyers, reveal that the company was aware of the presence of asbestos in its talc supply and the potential health risks associated with exposure. The lawsuit alleges that Johnson & Johnson actively concealed this information from the public and regulatory authorities.
The BBC reported on the case in October 2025, highlighting the allegations and the potential scale of the legal claim. The report detailed the concerns raised by lawyers and the evidence they intend to present in court. A similar story from the BBC also covered the Scottish group’s lawsuit. The article details the Scottish women’s legal action against Johnson & Johnson.
Stakeholders and Potential Outcomes
The primary stakeholders in this case are the claimants – the individuals who allege they developed cancer as a result of using Johnson & Johnson’s baby powder. Johnson & Johnson, as the defendant, faces significant financial and reputational risks. Regulatory bodies, such as the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), are also involved, as they are responsible for ensuring the safety of consumer products.
The potential outcomes of the case range from a settlement agreement, where Johnson & Johnson agrees to pay damages to the claimants, to a court ruling in favor of either party. If the claimants are successful, it could set a precedent for future product liability cases and lead to stricter regulations on the talc industry. It could also prompt Johnson & Johnson to re-evaluate its risk management practices and transparency policies.
The next step in the legal process is likely to involve further discovery, including the exchange of documents and witness depositions. A trial date has not yet been set, but the case is expected to be lengthy and complex. The outcome will be closely watched by legal experts, consumer advocates, and the pharmaceutical industry.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute legal advice. This proves essential to consult with a qualified legal professional for advice regarding your specific situation.
Share your thoughts on this developing story in the comments below. And please share this article with anyone who may be affected by these allegations.
